| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04a47dd46923cd79530d7163d00bac7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_018a7c5da05e75ecc2795d9a8ae6c98f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55f003e8284341b2b6f9d95642fd2895 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-703 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 |
| filingDate |
2005-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_804b22731c5053f0cd7c547c801861c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f71f89a0c0690018fa1b6e2c7332a73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6be28fb0eb715ae1a4350c4b58d6f18 |
| publicationDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006029934-A1 |
| titleOfInvention |
Methods of assessing HIV integrase inhibitor therapy |
| abstract |
The present invention relates to methods and products for the evaluation of HIV treatment. The methods are based on evaluating molecular events at the HIV integrase resulting in altered therapeutic efficacy of the investigated compounds. The methods rely on providing an integrase gene and evaluating either through genotyping or phenotyping said integrase gene. The present invention relates to the fields of diagnostics, drug screening, pharmacogenetics and drug development. |
| priorityDate |
2001-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |